Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2024 Dec 31;15(6):2743-2744.
doi: 10.21037/jgo-24-697. Epub 2024 Dec 5.

Pancreatic cancer: a haystack of needles

Nicholas L Michael  1 , Robert W Krell  1
Affiliations
Editorial

Pancreatic cancer: a haystack of needles

Nicholas L Michael et al. J Gastrointest Oncol. .
No abstract available

Keywords: Pancreatic cancer; mortality trends; racial disparities.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: Both authors have completed the ICMJE uniform disclosure form (available at https://jgo.amegroups.com/article/view/10.21037/jgo-24-697/coif). The authors have no conflicts of interest to declare.

Comment on

References

    1. Stoffel EM, Brand RE, Goggins M. Pancreatic Cancer: Changing Epidemiology and New Approaches to Risk Assessment, Early Detection, and Prevention. Gastroenterology 2023;164:752-65. 10.1053/j.gastro.2023.02.012 - DOI - PMC - PubMed
    1. Rahib L, Wehner MR, Matrisian LM, et al. Estimated Projection of US Cancer Incidence and Death to 2040. JAMA Netw Open 2021;4:e214708. 10.1001/jamanetworkopen.2021.4708 - DOI - PMC - PubMed
    1. Tan JY, Yeo YH, Ng WL, et al. Pancreatic cancer mortality trends in the United States: how much have we moved the needle? J Gastrointest Oncol 2024;15:1789-95. 10.21037/jgo-24-213 - DOI - PMC - PubMed
    1. United States Cancer Statistics - Mortality Incidence Rate Ratios: 1999 - 2021, WONDER Online Database. United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute; 2023 submission; 2024 release. Available online: http://wonder.cdc.gov/CancerMIR-v2021.html
    1. Conroy T, Desseigne F, Ychou M, et al. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N Engl J Med 2011;364:1817-25. 10.1056/NEJMoa1011923 - DOI - PubMed

LinkOut - more resources